Indrayani Biotech Delays FY26 Financial Results

Indrayani Biotech Ltd has announced a delay in the declaration of its audited financial results (standalone & consolidated) for the quarter and year ended March 31, 2026. The company cites consolidation of subsidiary results, operational disruptions, and the completion of internal and external audit processes as reasons for the delay. The board meeting to approve the results will be held at a later date, with prior intimation to be given. The trading window will remain closed until 48 hours after the declaration of the results.